SenesTech Inc. reported third quarter 2025 revenues of $0.7 million, a 43% increase from $0.5 million in the same period in 2024. Sales of Evolve Rodent Birth Control products rose 77% year-over-year and accounted for 85% of total revenue. Gross profit margin was 62.8%. The company reported a net loss of $1.3 million for Q3 2025, compared to a net loss of $1.5 million in Q3 2024. Adjusted EBITDA loss improved to $1.2 million from $1.4 million in the prior year. Cash and short-term investments totaled $10.2 million at the end of September 2025. E-commerce revenue grew 55% year-over-year, supported by double-digit growth in Amazon sales and increasing momentum on other platforms.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SenesTech Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA20384) on November 10, 2025, and is solely responsible for the information contained therein.